Moderna | MRNA - Stock


Moderna reported $146M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Alnylam Pharmaceuticals USD 200.15M 117.43M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Celltrion KRW 126B 3.06B Mar/2026
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Moderna USD 146M 7M Mar/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Pharma Mar EUR 53.12M 2.48M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Qiagen NV USD 301.89M 11.66M Dec/2025
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Sarepta Therapeutics USD 1B 86.37M Mar/2026
Sartorius EUR 827.1M 34.9M Mar/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
United Therapeutics USD 178.3M 4.8M Mar/2026
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026